PHIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phio Pharmaceuticals Corp (PHIO) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to justify immediate investment. Holding off for better opportunities is recommended.
The technical indicators are bearish. The MACD is negatively expanding below zero, the RSI is neutral at 38.897, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels, with a pivot at 1.267 and support at 1.214.
NULL. There is no recent news, no significant hedge fund or insider activity, and no recent congress trading data.
The company's financial performance is weak, with negative net income and declining EPS (-82.52% YoY). Technical indicators suggest a bearish trend.
In Q4 2025, revenue remained at 0 with no YoY growth. Net income improved by 45.82% YoY but remains negative at -$2,371,000. EPS dropped significantly by -82.52% YoY to -0.25. Gross margin is 0, indicating no profitability.
No analyst rating or price target changes available.
